PENICITIN 250MG CAP is a Schedule H drug. PENICITIN 250MG CAP is composed of: PENICILLAMINE (250.0 MG)
Tag: medicine for juvenile rheumatoid arthritis
ORENCIA 250MG INJ
ORENCIA 250MG INJ is a Schedule H drug. ORENCIA 250MG INJ is composed of: ABATACEPT (250.0 MG)
CILAMIN 250MG CAP
CILAMIN 250MG CAP is a Schedule H drug. CILAMIN 250MG CAP is composed of: PENICILLAMINE (250.0 MG)
ATRMIN 250MG CAP
ATRMIN 250MG CAP is a Schedule H drug. ATRMIN 250MG CAP is composed of: PENICILLAMINE (250.0 MG)
ARTAMIN 250MG CAP
ARTAMIN 250MG CAP is a Schedule H drug. ARTAMIN 250MG CAP is composed of: PENICILLAMINE (250.0 MG)
CILAMIN 250MG TAB
CILAMIN 250MG TAB is a Schedule H drug. CILAMIN 250MG TAB is composed of: PENICILLAMINE (250 MG)
TOLMETIN
TOLMETIN is a Schedule H drug.
PENICILLAMINE
PENICILLAMINE is a Schedule H drug.
CANAKINUMAB
Canakinumab is a monoclonal antibody that blocks certain proteins in the body that can affect inflammation and other immune responses. This medication is an interleukin-1 beta-blocker, prescribed for auto-inflammatory diseases known as cryopyrin-associated periodic syndrome (CAPS). It decreases interleukin-1 beta’s activity. Canakinumab is used to treat certain types of periodic fever syndromes, sometimes called auto-inflammatory syndromes. It is also approved to treat systemic juvenile idiopathic arthritis (SJIA) in children two years and older.
ABATACEPT
ABATACEPT is a Schedule H drug.